Mechanisms of antibody-dependent enhancement of infectious disease.

Autor: Wells TJ; Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia. timothy.wells@uq.edu.au., Esposito T; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Henderson IR; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Labzin LI; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. l.labzin@uq.edu.au.
Jazyk: angličtina
Zdroj: Nature reviews. Immunology [Nat Rev Immunol] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.
DOI: 10.1038/s41577-024-01067-9
Abstrakt: Antibody-dependent enhancement (ADE) of infectious disease is a phenomenon whereby host antibodies increase the severity of an infection. It is well established in viral infections but ADE also has an underappreciated role during bacterial, fungal and parasitic infections. ADE can occur during both primary infections and re-infections with the same or a related pathogen; therefore, understanding the underlying mechanisms of ADE is critical for understanding the pathogenesis and progression of many infectious diseases. Here, we review the four distinct mechanisms by which antibodies increase disease severity during an infection. We discuss the most established mechanistic explanation for ADE, where cross-reactive, disease-enhancing antibodies bound to pathogens interact with Fc receptors, thereby enhancing pathogen entry or replication, ultimately increasing the total pathogen load. Additionally, we explore how some pathogenic antibodies can shield bacteria from complement-dependent killing, thereby enhancing bacterial survival. We interrogate the molecular mechanisms by which antibodies can amplify inflammation to drive severe disease, even in the absence of increased pathogen replication. We also examine emerging roles for autoantibodies in enhancing the pathogenesis of infectious diseases. Finally, we discuss how we can leverage these insights to improve vaccine design and future treatments for infectious diseases.
(© 2024. Springer Nature Limited.)
Databáze: MEDLINE
Externí odkaz: